In-depth technical white papers on HiTE™ and lentiviral transduction will live here. The current HiTE™ white paper is available below; additional white papers are in development and will appear in this section as they're released.
The full technical white paper on HiTE™ — mechanism of action, validation across primary T cells, NK cells, and iPSCs, viability and VCN data, and process implications for late-stage and commercial cell therapy manufacturing.
Download White Paper (PDF)We're preparing additional technical papers covering process integration, GMP manufacturing implications, and indication-specific deep-dives. If you'd like to be notified when new white papers are published, drop us a line.
Notify me when new white papers are published